Cargando…

Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: A Prospective Interventional Trial

INTRODUCTION: The interaction between anticoagulants and platelet function is complex. Previous publications showed mixed results regarding the role of heparins in platelet aggregation. On the other hand, the direct thrombin inhibitor (DTI) dabigatran might enhance the risk of myocardial infarction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arantes, Flávia B. B., Menezes, Fernando R., Franci, Andre, Barbosa, Carlos J. D. G., Dalçoquio, Talia F., Nakashima, Carlos A. K., Baracioli, Luciano M., Furtado, Remo H. M., Nomelini, Quintiliano S. S., Ramires, José A. F., Kalil Filho, Roberto, Nicolau, José C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979460/ https://www.ncbi.nlm.nih.gov/pubmed/31758517 http://dx.doi.org/10.1007/s12325-019-01153-8

Ejemplares similares

Platelet function, coagulation and fibrinolysis in patients with previous coronary and cerebrovascular ischemic events
por: Barbosa, Carlos José Dornas Gonçalves, et al.
Publicado: (2019)

Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction
por: Genestreti, Paulo R. Rizzo, et al.
Publicado: (2022)

Factors associated with actively working in the very long-term following acute coronary syndrome
por: Nicolau, Jose C., et al.
Publicado: (2021)

Do Diabetic Patients with Acute Coronary Syndromes Have a Higher Threshold for Ischemic Pain?
por: Nicolau, José Carlos, et al.
Publicado: (2014)

Associação entre Terapia com Estatinas e Menor Incidência de Hiperglicemia em Pacientes Internados com Síndromes Coronarianas Agudas
por: Furtado, Remo Holanda de Mendonça, et al.
Publicado: (2021)

Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease
por: Salsoso, Rocío, et al.
Publicado: (2020)

Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
por: Barbosa, Carlos J.D.G., et al.
Publicado: (2019)

Cardiology Training in Brazil and Developed Countries: Some Ideas for Improvement
por: Godoy, Lucas Colombo, et al.
Publicado: (2019)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Platelet Reactivity and Coagulation Markers in Patients with COVID-19
por: Bertolin, Adriadne J., et al.
Publicado: (2021)

SBC Guidelines on Unstable Angina and Non-ST-Elevation Myocardial Infarction: Executive Summary
por: Feitosa-Filho, Gilson Soares, et al.
Publicado: (2015)

In Patients With Acute Myocardial Infarction, the Impact of Hyperglycemia as a Risk Factor for Mortality Is Not Homogeneous Across Age-Groups
por: Nicolau, José Carlos, et al.
Publicado: (2012)

The Bleeding Risk Score as a Mortality Predictor in Patients with Acute Coronary Syndrome
por: Nicolau, José Carlos, et al.
Publicado: (2013)

Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction
por: Furtado, Remo H.M., et al.
Publicado: (2022)

Influência do Exercício Físico sobre a Mecânica de Contração do Ventrículo Esquerdo após Infarto do Miocárdio
por: Lima, Márcio Silva Miguel, et al.
Publicado: (2023)

Thrombin Decrease in Thrombin Generation after Heparin Administration in a Homozygous Type II Heparin-Binding Site Antithrombin-Deficient Pregnant Woman
por: Malíková, Ivana, et al.
Publicado: (2023)

Validation of high concentrated thrombin time assay for unfractionated heparin monitoring
por: Apipongrat, Dollapak, et al.
Publicado: (2022)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Effect of a Direct Thrombin Inhibitor Compared with Dalteparin and Unfractionated Heparin on Human Osteoblasts
por: Winkler, Tobias, et al.
Publicado: (2011)

Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin
por: Tykesson, Emil, et al.
Publicado: (2019)

The Role of Invasive Therapies in Elderly Patients with Acute Myocardial Infarction
por: Nicolau, José C., et al.
Publicado: (2009)

Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
por: Mirdamadi, Ahmad
Publicado: (2013)

On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different
por: Mosier, Philip D., et al.
Publicado: (2012)

The Tick-Derived Anticoagulant Madanin Is Processed by Thrombin and Factor Xa
por: Figueiredo, Ana C., et al.
Publicado: (2013)

New Insights in Thrombin Inhibition Structure–Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin †
por: Mourier, Pierre A. J., et al.
Publicado: (2017)

Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification
por: Serrano, Carlos V, et al.
Publicado: (2011)

Association between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios and Coronary Artery Calcification Score among Asymptomatic Patients: Data from a Cross-Sectional Study
por: Serrano, Carlos V., et al.
Publicado: (2019)

Pharmacological Modulation by Low Molecular Weight Heparin of Purinergic Signaling in Cardiac Cells Prevents Arrhythmia and Lethality Induced by Myocardial Infarction
por: Filho, Carlos Eduardo Braga, et al.
Publicado: (2023)

Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance
por: Torreão, Jorge A., et al.
Publicado: (2015)

High Residual Platelet Reactivity during Aspirin Therapy in Patients with Non-St Segment Elevation Acute Coronary Syndrome: Comparison Between Initial and Late Phases
por: Dracoulakis, Marianna Deway Andrade, et al.
Publicado: (2019)

The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand
por: Boyle, Amanda J, et al.
Publicado: (2013)

Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses
por: Lund, Mikael, et al.
Publicado: (2021)

Direct thrombin inhibitors as alternatives to heparin to preserve lung growth and function in a murine model of compensatory lung growth
por: Tsikis, Savas T., et al.
Publicado: (2022)

Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus
por: Sprandel, Marilia C O, et al.
Publicado: (2015)

Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19
por: Lazari, Lucas Cardoso, et al.
Publicado: (2021)

Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor
por: Sakai, Togo, et al.
Publicado: (2022)

PURIFICATION OF THROMBIN
por: Milstone, H.
Publicado: (1942)

Single-Breathhold Four-Dimensional Assessment of Left Ventricular Morphological and Functional Parameters by Magnetic Resonance Imaging Using the VAST Technique
por: Rochitte, Carlos Eduardo, et al.
Publicado: (2011)

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases
por: Langford-Smith, Kia Jane, et al.
Publicado: (2010)

Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis
por: M’Pembele, René, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bs71g02pv08i7u6jmrt09kn9qq